PATENT CLAIM ANALYSIS

Application Number: 15756043
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "133100"]

Abstract:
The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a Siglec-7 protein, e.g., human Siglec-7 or a mammalian Siglec-7, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Claim (Index 31):
An isolated monoclonal anti-Siglec-7 antibody, wherein the anti-Siglec-7 antibody binds to one or more amino acid residues selected from the group consisting of M30, Q31, V44, R45, S47, F48, Y50, I72, W74, N81, T103, K104, T107, and R124 of SEQ ID NO: 1, or one or more amino acid residues on a mammalian Siglec-7 protein corresponding to an amino acid residue selected from the group consisting of M30, Q31, V44, R45, S47, F48, Y50, I72, W74, N81, T103, K104, T107, and R124 of SEQ ID NO: 1.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 88.0
- Lexical Diversity: 1.46667
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14565370', '14021777', '15222849', '15182327', '15222848']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7925475749088429
- 35 USC 102 Novelty (BERT): 0.5870936695574163
- Combined Prediction Score: 0.7720021843737002
- Mean Citation Score: 461.736258
- Max Citation Score: 500.8059
- Similarity Product: 383.9612117601157

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test